Latest News and Press Releases
Want to stay updated on the latest news?
-
TORONTO, Ontario and HAIFA, Israel and POMPANO BEACH, Florida, April 07, 2026 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) and...
-
New York, NY, April 07, 2026 (GLOBE NEWSWIRE) -- Today, Candid and ABFE- A Philanthropic Partnership for Black Communities released From Transaction to Transformation: Three Ways Foundations Can...
-
SAN FRANCISCO, April 07, 2026 (GLOBE NEWSWIRE) -- Digits, the world’s first AI-native accounting platform, today introduced outcome-based pricing for accounting firms, becoming the first platform in...
-
Fremont, CA, April 07, 2026 (GLOBE NEWSWIRE) -- ASUS today announced the U.S. availability of its latest Zenbook lineup, headlined by the all-new Zenbook A16. Setting a new standard for...
-
Green Rain Energy Holdings Advances EV Infrastructure Across U.S. Markets as Execution Translates into Revenue Opportunity
-
Company to Pursue Additional PMTA Submissions, Building on Its Status as the Only Holder of an FDA-Authorized Low Nicotine Combustible Cigarette Branded as VLN® Products Expanded PMTA Portfolio and...
-
Smithfield® and Pabst Blue Ribbon Kick Off Grilling Season with a Bold New Beer Brat
-
Mr. Taylor brings a strong track record launching multiple high-profile therapies, most recently serving as Senior Vice President, Sales at Arcutis Biotherapeutics (Nasdaq: ARQT), where he led U.S....
-
Marvel announces financial and strategic backing from 5 Horizons Ventures to support its upcoming Phase 1 clinical trial of patented lead asset MB-204
-
NEW YORK, April 07, 2026 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative...